- Home
- YHGJ vs AEON Comparison
YHGJ vs AEON Comparison
Compare YHGJ & AEON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$4.34
HOLD
Current Price
$0.97
Company Overview
Basic Information| Metric | YHGJ | AEON |
|---|---|---|
| Founded | 1975 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Specialty Chemicals | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.3M | 10.6M |
| IPO Year | 1997 | N/A |
Fundamental Metrics
Financial Performance| Metric | YHGJ | AEON |
|---|---|---|
| Price | $4.34 | $0.97 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $7.20 |
| AVG Volume (30 Days) | 15.7K | ★ 165.8K |
| Earning Date | 11-13-2025 | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $19,377,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 4.41 | N/A |
| 52 Week Low | $4.00 | $0.38 |
| 52 Week High | $12.70 | $49.11 |
Technical Indicators
Market Signals| Indicator | YHGJ | AEON |
|---|---|---|
| Relative Strength Index (RSI) | 39.38 | 59.30 |
| Support Level | $4.30 | $0.72 |
| Resistance Level | $5.43 | $1.10 |
| Average True Range (ATR) | 0.33 | 0.09 |
| MACD | -0.07 | 0.03 |
| Stochastic Oscillator | 13.61 | 72.51 |
Price Performance
Historical Comparison YHGJ
AEON
About YHGJ Yunhong Green CTI Ltd.
Yunhong Green CTI Ltd manufactures and marketers of foil balloons and produces laminated and printed films for commercial uses. The company also distributes balloon-inspired and other gift items, and continues development of compostable material solutions, and markets its products throughout the United States and in several other countries.
About AEON AEON Biopharma Inc.
AEON Biopharma Inc is a clinical stage biopharmaceutical company focused on developing of its proprietary botulinum toxin complex ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, with an initial focus on the neurosciences market.